Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 30.21 | 57.88 | 8.29 | 4.94 |
Short Term Investments | 42.19 | 81.06 | 26.51 | 73.76 |
Cashand Short Term Investments | 72.40 | 150.89 | 63.99 | 88.97 |
Accounts Receivable- Trade Net | 425.13 | 354.20 | 304.97 | 145.08 |
Total Receivables Net | 425.83 | 367.59 | 326.33 | 161.22 |
Total Inventory | 282.33 | 198.87 | 213.35 | 104.04 |
Other Current Assets Total | 64.22 | 0.35 | 0.68 | 0.00 |
Total Current Assets | 844.79 | 721.16 | 609.29 | 354.72 |
Property/ Plant/ Equipment Total- Gross | 47.21 | 448.65 | 428.82 | 216.64 |
Property/ Plant/ Equipment Total- Net | 361.90 | 326.68 | 347.99 | 168.19 |
Goodwill Net | 118.71 | 118.71 | 89.86 | 2.62 |
Intangibles Net | 144.15 | 154.30 | 170.64 | 10.76 |
Long Term Investments | 0.21 | 0.23 | 0.40 | 19.52 |
Note Receivable- Long Term | 30.54 | 43.17 | 37.02 | 5.10 |
Other Long Term Assets Total | 71.85 | 3.32 | 1.53 | 0.43 |
Total Assets | 1,572.15 | 1,367.57 | 1,256.72 | 561.35 |
Accounts Payable | 219.10 | 185.19 | 186.15 | 131.11 |
Notes Payable/ Short Term Debt | 72.50 | 29.01 | 8.43 | 0.00 |
Current Portof LT Debt/ Capital Leases | 2.06 | 9.98 | - | 0.00 |
Other Currentliabilities Total | 131.08 | 118.42 | 92.06 | 15.19 |
Total Current Liabilities | 424.74 | 346.86 | 294.66 | 150.19 |
Long Term Debt | 33.32 | 34.93 | 85.03 | 0.00 |
Capital Lease Obligations | 10.91 | - | - | - |
Total Long Term Debt | 44.23 | 34.93 | 85.03 | 0.00 |
Total Debt | 118.79 | 73.93 | 93.45 | 0.00 |
Deferred Income Tax | 51.47 | 58.72 | 68.95 | 1.29 |
Other Liabilities Total | 3.98 | 11.88 | 2.92 | 1.10 |
Total Liabilities | 524.42 | 452.40 | 451.56 | 152.58 |
Common Stock Total | 11.05 | 11.03 | 11.01 | 10.39 |
Retained Earnings( Accumulated Deficit) | 1,036.68 | 440.08 | 335.06 | 240.84 |
Total Equity | 1,047.73 | 915.17 | 805.16 | 408.77 |
Total Liabilities Shareholders' Equity | 1,572.15 | 1,367.57 | 1,256.72 | 561.35 |
Total Common Shares Outstanding | 5.52 | 5.52 | 5.51 | 5.19 |
Tangible Book Valueper Share Common Eq | 142.07 | 116.43 | 98.93 | 76.14 |
Cash | - | 11.96 | 29.19 | 10.27 |
Prepaid Expenses | - | 3.46 | 4.95 | 0.49 |
Accumulated Depreciation Total | - | -121.96 | -80.83 | -48.45 |
Accrued Expenses | - | 4.26 | 8.02 | 3.88 |
Additional Paid- In Capital | - | 464.06 | 459.10 | 157.55 |
Minority Interest | - | - | - | 0.00 |
Rossari Biotech Dividend Rossari Biotech Bonus Rossari Biotech News Rossari Biotech AGM Rossari Biotech Rights Rossari Biotech Splits Rossari Biotech Board Meetings Rossari Biotech Key Metrics Rossari Biotech Shareholdings Rossari Biotech Profit Loss Rossari Biotech Cashflow Rossari Biotech Q1 Results Rossari Biotech Q2 Results Rossari Biotech Q3 Results Rossari Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks